September 24, 2008
Medivisor, Inc. Receives Initial Purchase Order
Medivisor, Inc. (PINKSHEETS: MVSR) developer of next-generation, focus driven marketing tools primarily for pharmaceutical companies, is pleased to announce that it has received a purchase order for Albumax from Critical Healthcare Solutions, Inc. for their East Goshen Pharmacy Inc. unit.
"After completing our sales and marketing agreement for Albumax just a few weeks ago, our initial marketing efforts are already starting to pay off. We are already beginning to see a strong interest in the product, have received Medicaid approval in New York, and are pleased to announce this initial purchase order for Albumax in such a short period of time," stated Dino Luzzi, CEO of Medivisor, Inc. "Our marketing efforts are just getting underway and as we continue to bring awareness of Albumax to the marketplace, we anticipate further purchase order announcements," continued Mr. Luzzi.
Under a recently announced agreement with Cura Pharmaceutical Co., Inc. Medivisor is responsible for marketing and sales of Albumax, a whey protein isolate formula that makes it easy for kidney disorder patients to reach their daily requirements of high quality protein in their diet. Patients and those in the Medical Profession can now go to www.albumax.net to order or inquire about the product.
About Medivisor, Inc.:
Medivisor, Inc. is a developer of next-generation, focus driven marketing tools, dedicated to providing technologies that offer innovative and competitive advantages to the bioscience and pharmaceutical markets. From pre-product development through product launch and commercialization, Medivisor offers worldwide experience in delivering effective and successful integrated marketing and creative communications campaigns for the benefit of its clients.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") Additionally, words such as "seek,""intend,""believe,""plan,""estimate,""expect,""anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the events or results anticipated by these forward-looking statements may not occur. Further information on Medivisor risk factors is contained in its filings with the Securities and Exchange Commission. Medivisor does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Contact: Dino Luzzi CEO Medivisor, Inc. Tel: 631.549.7100 Email Contact
SOURCE: Medivisor, Inc.